Author

Simona D'Agnelli

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Oct 2026

Baseline circulating immunophenotype as a predictor of immune-related adverse events in NSCLC patients treated with immune checkpoint inhibitors.

BACKGROUND Immune-related adverse events (irAEs) represent a challenge in non-small cell lung cancer (NSCLC) patients receiving immune checkpoint inhibitors (IO). Baseline circulating immunophenotype may identify patients at increased irAEs risk. METHODS This observational study included patients with advanced NSCLC...

A. Dodi, G. Mazzaschi, F. Pecci et al. · Immunotherapy · 0 citations

Open access Sep 2026

Minimal residual disease combined with radiological tumor volume as a tool for identification of resected NSCLC patients at high risk of recurrence

Introduction Circulating tumor DNA (ctDNA) is a valuable tool for assessing minimal residual disease (MRD) and predicting recurrence in resected non-small cell lung cancer (NSCLC) patients. Combining ctDNA-detection with radiological tumor volume may improve risk stratification. Methods Patients with stage I-III resect...

M. Verzè, R. Minari, P. Bordi et al. · The journal of liquid biopsy · 0 citations